Child-Turcotte-Pugh Class is Best at Stratifying Risk in Variceal Hemorrhage
Brett E. Fortune(Montefiore Medical Center), Roberto J. Groszmann(Yale University), Guadalupe García–Tsao(Connecticut Health Foundation), Adrian Reuben(Medical University of South Carolina), Hugo E. Vargas(Mayo Clinic in Arizona), Tarek Hassanein, Samuel H. Sigal(New York University), Michele D. Lewis(Jacksonville College), Michael B. Fallon(University of Arizona), Joseph K. Lim(Yale Cancer Center), Maria Ciarleglio(Yale University), Arun J. Sanyal(Virginia Commonwealth University), Naga Chalasani(Indiana University – Purdue University Indianapolis), Kimberly L. Beavers(Medical University of South Carolina), Daniel Ganger(Northwestern University), Gary A. Abrams(University of Alabama at Birmingham), Norman D. Grace(Brigham and Women's Hospital), James F. Trotter(Baylor Scott & White Health), Paul J. Thuluvath(University of Maryland, Baltimore), Yanhong Deng(Sun Yat-sen University)
Cited by 94
Related Papers
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
|Hepatology|2017|7.2k
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
|New England Journal of Medicine|2010|3.3k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k